Birchview Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Birchview Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-22,000	Closed	-$2.04M	–	68
2021 Q4	$2.04M	Hold	22,000	–	–	1.32%	13
2021 Q3	$1.31M	Hold	22,000	–	–	0.89%	23
2021 Q2	$1.5M	Hold	22,000	–	–	0.9%	19
2021 Q1	$1.53M	Hold	22,000	–	–	0.91%	20
2020 Q4	$1.69M	Hold	22,000	–	–	0.97%	18
2020 Q3	$1.65M	Hold	22,000	–	–	1.1%	17
2020 Q2	$1.39M	Hold	22,000	–	–	0.84%	19
2020 Q1	$924K	Hold	22,000	–	–	0.82%	18
2019 Q4	$999K	Hold	22,000	–	–	0.73%	22
2019 Q3	$1.01M	Hold	22,000	–	–	0.67%	14
2019 Q2	$1.29M	Hold	22,000	–	–	0.78%	11
2019 Q1	$986K	Hold	22,000	–	–	0.62%	14
2018 Q4	$857K	Hold	22,000	–	–	0.81%	15
2018 Q3	$1.01M	Sell	22,000 -3,000	-12%	-$122K	0.65%	17
2018 Q2	$1.09M	Buy	25,000 +15,000	+150%	+$645K	0.74%	16
2018 Q1	$395K	Buy	+10,000	New	+$389K	0.26%	34

Birchview Capital's ARNA Position: Q1 2022 in Review

Birchview Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 22,000 shares — an estimated $2.04M sold.

Birchview Capital first reported a position in ARNA in Q1 2018 and held it in 16 quarters. The position peaked at $2.04M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Birchview Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Birchview Capital sold 22,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.04M.
Birchview Capital first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 16 quarters.
Birchview Capital's Arena Pharmaceuticals Inc position peaked at $2.04M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Birchview Capital's 13F filing for Q1 2022, filed 13 May 2022.